Immunotherapy is a kind of cancer treatment in which the immune system is used to target cancer cells in the same manner that it would attack germs or viruses.
This treatment aims to harness several kinds of immune cells that circulate in your body and has the potential to offer long-term advantages. Simply stated, immunotherapy treats your body as cancer treats your body.
Cancer immunotherapy has made significant advancements in recent years, and this treatment is presently being explored for a variety of cancer types.
There are FDA-approved immunotherapies for a variety of malignancies, including melanoma, lung cancer, kidney cancer, bladder cancer, and lymphoma, and many more are in the works.
Immunotherapy may be administered as a medication or as a cell-based treatment, in which we harvest and alter a patient’s own immune cells before reinfusing them into the body.
Checkpoint inhibitors operate by removing a natural brake on your immune system, allowing T cells, which are immune cells, to identify and kill tumours.
Chimeric antigen receptor (CAR) T cell treatment involves genetically engineering a patient’s own immune cells to produce a novel protein. As a result, they become supercharged cancer fighters.
Cancer vaccinations that are therapeutic teach your body to defend itself against its own damaged or aberrant cells, including cancer cells.